Mast Therapeutics (MSTX) Tops Q2 EPS by 1c

August 9, 2016 8:20 AM EDT
Get Alerts MSTX Hot Sheet
Trade MSTX Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Mast Therapeutics (NYSE: MSTX) reported Q2 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Mast Therapeutics (MSTX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment